Evidence map›Paper›PMID 37435185›Full record

ArticleEndocrine oncology (Bristol, England)2021

Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding.

Nada Younes, Isabelle Bourdeau, Harold Olney, Paul Perrotte, Odile Prosmanne, Mathieu Latour, David Roberge, André Lacroix

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Endocrine oncology (Bristol, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nada YounesDivision of Endocrinology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Isabelle BourdeauDivision of Endocrinology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Harold OlneyDivision of Hematology and Medical Oncology, Department of Medicine, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Paul PerrotteDivision of Urology, Department of Surgery, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Odile ProsmanneDepartment of Radiology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Mathieu LatourDepartment of Pathology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
David RobergeDivision of Radiation Oncology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
André LacroixDivision of Endocrinology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Centre Hospitalier de l’Université de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Needle tract seeding is a potential, albeit rare, complication following transcutaneous biopsies, leading to the seeding of tumor cells along the path of the needle. Biopsies of adrenal masses are not routinely recommended and are only indicated, after exclusion of pheochromocytoma, when an adrenal metastasis of a primary extra-adrenal cancer is suspected or when pathological confirmation of inoperable adrenocortical cancer (ACC) may impact treatment. Despite guideline recommendations to avoid primary adrenal biopsy, very few needle tract seeding cases have been reported and none were in the context of an ACC. We report the occurrence of needle tract seeding in a patient following adrenal transcutaneous biopsy leading to ACC abdominal wall recurrence. Learning points: Needle tract seeding is a rare complication of transcutaneous biopsy. It may increase morbidity and impact overall survival. It has yet to be documented in adrenocortical carcinoma (ACC).Adrenal masses can be accurately evaluated for malignancy using a combination of conventional and metabolic imaging, such as CT and fluorodeoxyglucose-PET, obviating the need for biopsies.Adrenal mass biopsy is not indicated in ACC unless advanced ACC is diagnosed, and a pathological confirmation would impact management.

Indexed as

adrenocortical carcinomametastasisneedle biopsy

Identifiers

PMID37435185
PMCPMC10265540
OpenAlexW3212243488

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.